M&A / Deals Merck KGaA acquires JSR chromatography business Pharmaceutical Business ReviewThis follows the company's signing of a definitive agreement in October 2025 to acquire the business.M&A / DealsRead full story pharminent April 2, 2026 (Last updated: April 2, 2026) Pharmaceutical Business Review This follows the company’s signing of a definitive agreement in October 2025 to acquire the business. M&A / DealsRead full story Please leave this field emptySign up to receive free daily digest Check your inbox or spam folder to confirm your subscription. Post navigation Previous: Biocytogen and Sihuan partner to advance new therapeutics for weight lossNext: Building What’s Next: Join Industry Leaders to Shape Access and Affordability Trends Ahead of Asembia AXS26 Related Stories M&A / Deals J&J ventures further into in vivo CAR-T space with Sail partnership, potential buyout pharminent July 31, 2026 M&A / Deals Eisai and CORE Biomedicine agree on global licence for oncology pipeline pharminent July 29, 2026 M&A / Deals Argenx signs agreement to buy Forte Biosciences for $2.2bn pharminent July 28, 2026
